The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

Abby Jones’ first stop of the day delivering medication was the home of 90-year-old Sarah Campbell Kier. “Come in!” yelled ...

FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.

"Given the fact that there are states, counties, cities, school districts, pension funds, and other plaintiffs from all over ...

On his first day in office, President Donald Trump signed multiple executive orders and even rescinded one from his predecessor, President Joe Biden, that planned to lower prescription drug costs.

The suit comes exactly one year after 22-year-old Cole Schmidtknecht died from cardiac arrest after suffering a severe asthma attack.

As investors react to an ever-changing political climate, Ash Shehata from KPMG explains what factors they're paying ...

In 2024, the FDA approved 19 biosimilars across various therapeutic areas, including the first biosimilars for ustekinumab ...

According to a recent KFF poll, the majority of Americans believe that the cost of prescription drugs is too high, and those ...

The majority of Americans think prescription drug costs are unreasonable and believe a major contributor to the high cost is ...

A US government report has found that three of the country’s largest pharmacy benefit managers (PBMs) “hiked costs” of ...

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of ...